Congenericity of Claimed Compounds in Patent Applications

A method is presented to analyze quantitatively the degree of congenericity of claimed compounds in patent applications. The approach successfully differentiates patents exemplified with highly congeneric compounds of a structurally compact and well defined chemical series from patents containing a...

Descripción completa

Detalles Bibliográficos
Autores principales: Falaguera, Maria J., Mestres, Jordi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433967/
https://www.ncbi.nlm.nih.gov/pubmed/34500686
http://dx.doi.org/10.3390/molecules26175253
_version_ 1783751487073026048
author Falaguera, Maria J.
Mestres, Jordi
author_facet Falaguera, Maria J.
Mestres, Jordi
author_sort Falaguera, Maria J.
collection PubMed
description A method is presented to analyze quantitatively the degree of congenericity of claimed compounds in patent applications. The approach successfully differentiates patents exemplified with highly congeneric compounds of a structurally compact and well defined chemical series from patents containing a more diverse set of compounds around a more vaguely described patent claim. An application to 750 common patents available in SureChEMBL, SureChEMBLccs and ChEMBL is presented and the congenericity of patent compounds in those different sources discussed.
format Online
Article
Text
id pubmed-8433967
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84339672021-09-12 Congenericity of Claimed Compounds in Patent Applications Falaguera, Maria J. Mestres, Jordi Molecules Article A method is presented to analyze quantitatively the degree of congenericity of claimed compounds in patent applications. The approach successfully differentiates patents exemplified with highly congeneric compounds of a structurally compact and well defined chemical series from patents containing a more diverse set of compounds around a more vaguely described patent claim. An application to 750 common patents available in SureChEMBL, SureChEMBLccs and ChEMBL is presented and the congenericity of patent compounds in those different sources discussed. MDPI 2021-08-30 /pmc/articles/PMC8433967/ /pubmed/34500686 http://dx.doi.org/10.3390/molecules26175253 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Falaguera, Maria J.
Mestres, Jordi
Congenericity of Claimed Compounds in Patent Applications
title Congenericity of Claimed Compounds in Patent Applications
title_full Congenericity of Claimed Compounds in Patent Applications
title_fullStr Congenericity of Claimed Compounds in Patent Applications
title_full_unstemmed Congenericity of Claimed Compounds in Patent Applications
title_short Congenericity of Claimed Compounds in Patent Applications
title_sort congenericity of claimed compounds in patent applications
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433967/
https://www.ncbi.nlm.nih.gov/pubmed/34500686
http://dx.doi.org/10.3390/molecules26175253
work_keys_str_mv AT falagueramariaj congenericityofclaimedcompoundsinpatentapplications
AT mestresjordi congenericityofclaimedcompoundsinpatentapplications

Ejemplares similares